Equities

Iovance Biotherapeutics Inc

Iovance Biotherapeutics Inc

Actions
  • Price (USD)9.18
  • Today's Change-0.611 / -6.24%
  • Shares traded107.99k
  • 1 Year change+131.12%
  • Beta--
Data delayed at least 20 minutes, as of Nov 13 2024 19:03 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Iovance Biotherapeutics Inc fell by 56.84m. Cash Flow from Financing totalled 462.96m or 38,936.84% of revenues. In addition the company used 361.82m for operations while cash used for investing totalled 155.24m.
Cash flow per share-1.36
Price/Cash flow per share--
Book value per share2.54
Tangible book value per share1.53
More ▼

Balance sheet in USDView more

Iovance Biotherapeutics Inc uses little debt in its capital structure as supported by a debt to capital ratio of 0.13%.
Current ratio4.22
Quick ratio3.90
Total debt/total equity0.0013
Total debt/total capital0.0013
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.